Who Owns Citius Oncology Stock?
NASDAQ: CTORHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 15.21%
- Held by insiders
- 77.51%
- Institutional holders
- 20
- Institutions 15.2%
- Insiders 77.5%
- Public and other 7.3%
Who owns Citius Oncology stock?
Institutional investors own about 15.2% of Citius Oncology's shares, spread across 20 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 77.51% of CTOR.
The largest institutional holders are Armistice Capital, LLC (9.36%), Bank of America Corporation (4.12%) and Vanguard Capital Management LLC (0.59%). Together, the top 10 institutions control 15.1% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their CTOR positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CTOR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Armistice Capital, LLC | 8.71M | 9.36% | -5.3% |
| Bank of America Corporation | 3.84M | 4.12% | 0.0% |
| Vanguard Capital Management LLC | 546.33K | 0.59% | +2.1% |
| UBS Group AG | 334.62K | 0.36% | +808.3% |
| Geode Capital Management, LLC | 245.41K | 0.26% | -7.3% |
| Vanguard Fiduciary Trust Co | 121.91K | 0.13% | 0.0% |
| IFP Advisors, Inc | 107.42K | 0.12% | 0.0% |
| Citadel Advisors Llc | 90.59K | 0.10% | +100.0% |
| Northern Trust Corporation | 45.75K | 0.05% | 0.0% |
| State Street Corporation | 42.90K | 0.05% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CTOR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 370.10K | 0.40% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 176.22K | 0.19% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 98.01K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 54.73K | 0.06% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 26.29K | 0.03% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 23.39K | 0.03% |
Frequently asked questions
Who is the largest shareholder of Citius Oncology?
Armistice Capital, LLC is the largest institutional shareholder of CTOR, owning 9.36% of shares outstanding (8.71M shares) as of its latest 13F filing.
What percentage of Citius Oncology is owned by institutions?
Institutions own about 15.2% of CTOR shares and 67.6% of the public float.
How much of Citius Oncology do insiders own?
Insiders, such as officers and directors, own about 77.51% of CTOR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.